{"disease":{"id":"transfusion-dependent-beta-thalassaemia","name":"transfusion dependent beta thalassaemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04925206","title":"A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"EdiGene (GuangZhou) Inc.","has_results":false},{"nct_id":"NCT04390971","title":"Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT05752123","title":"A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.","phase":"NA","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"EdiGene (GuangZhou) Inc.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}